Patients

Etre soigné dans un Centre de lutte contre le cancer

Découvrez notre démarche

Professionnels de santé

La recherche et la prise en charge UNICANCER

Accédez à votre espace

Vous cherchez un Centre

Les 20 centres de lutte contre le cancer sur l'ensemble du territoire

Voir tous les Centres
Accueil » La recherche UNICANCER » R&D UNICANCER » Les publications de R&D UNICANCER » Communications orales et posters

Communications R&D UNICANCER

19/12/2011

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: ...

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

19/12/2011

Safety profile of Ixabepilone as adjuvant treatment for poor prognosis early breast cancer: first results of the ...

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

19/12/2011

Correlation of circulating tumor cells (CTC) and circulating endothelial cells (CEC) with pathological Complete ...

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

19/12/2011

Multicentric Phase II PACS 09/Beverly1 Trial: First Efficacy And Safety Results Of Neoadjuvant Chemotherapy Combined ...

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

19/12/2011

Circulating Tumor Cells (CTC) monitoring during phase II study with lapatinib (L) and capecitabine (C) in patients ...

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

19/12/2011

SAFIR01: A Molecular Screening Trial for Metastatic Breast Cancer Patients

34th SABCS (San Antonio Breast Cancer Symposium) - San Antonio, 6-10 décembre 2011

28/11/2011

Efficacy and safetyof bevacizumab (bev)-based combination regimens in patientswith metastatic colorectal cancer ...

ASCO (American Society of Clinical Orlando) Annual Meeting - Orlando, 29 mai - 2 juin 2009

08/12/2010

Beverly 2, a phase II study evaluating bevacizumab combined with chemotherapy and trastuzumab as neoadjuvant therapy ...

SABCS (San Antonio Breast Cancer Symposium) – Texas, 8-12 décembre 2010

21/10/2010

Phase II Study of cis-platinimum and oral VP16 in patients with a refractory or relapsed ewing sarcoma or a ewing ...

Annual Congress of the International Society of Paediatric Oncology (SIOP) Boston, 21-24 octobre 2010

08/10/2010

A pooled analysis of the final results of the two randomized phase II studies comparing Gemcitabine (G) vs ...

ESMO (European Society for Medical Oncology) - Milan, 8-12 octobre 2010